Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07113457 · ClinicalTrials.gov registry record · NA

Assessing Upper Extremity Function in Chronic Stroke Survivors Through Acute Intermittent Hypoxia

A NA study of Stroke, sponsored by Shirley Ryan AbilityLab.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07113457: Active NA study of Stroke, sponsored by Shirley Ryan AbilityLab.

NCT07113457 is a NA study of Stroke that is active but no longer recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 20 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07113457, a NA study of Stroke, is active but no longer recruiting, sponsored by Shirley Ryan AbilityLab.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Here we aim to observe effects of acute intermittent hypoxia in persons who have experienced a single stroke. We have previously shown this technique to be safe and effective at increasing strength in persons with disabilities, and here are aiming to determine the mechanism of how the breathing method modulates motor function.

Conditions Studied

Interventions

  • OTHER Acute Intermittent Hypoxia (AIH)

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-06-02
Est. Completion 2027-08
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT07113457

The ClinicalTrials.gov registry entry for NCT07113457 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Acute Intermittent Hypoxia (AIH) is the first listed.

NCT07113457 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07113457 about?

NCT07113457 is a clinical study titled "Assessing Upper Extremity Function in Chronic Stroke Survivors Through Acute Intermittent Hypoxia". Here we aim to observe effects of acute intermittent hypoxia in persons who have experienced a single stroke. We have previously shown this technique to be safe and effective at increasing strength in persons with disabilities, and here are aiming to determine the mechanism of how the breathing meth...

What is the current status of trial NCT07113457?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-06-02. Estimated completion is 2027-08.

What conditions does trial NCT07113457 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT07113457?

The interventions under investigation include: Acute Intermittent Hypoxia (AIH) (OTHER).

Who is sponsoring clinical trial NCT07113457?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07113457 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.